PROCEPT BioRobotics Corporation - Common Stock — Quarterly Cash Flow (NASDAQ:PRCT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Total assets 519.38 M513.05 M511.54 M508.08 M487.06 M479.35 M Total liabilities 130.22 M127.26 M131.26 M142.21 M139.4 M139.28 M Total equity 389.16 M385.8 M380.28 M365.87 M347.67 M340.07 M Total liabilities & shareholders' equities 519.38 M513.05 M511.54 M508.08 M487.06 M479.35 M Total debt 51.5 M51.52 M51.57 M51.62 M51.66 M51.72 M Net debt 51.5 M51.52 M-242.72 M-234.89 M-193.98 M-176.2 M

News

PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Beats Revenue Estimates

Procept BioRobotics: Filling Robots Slower Than Placing Them (NASDAQ:PRCT)

Why This Group Of Medical Giants, Including Intuitive Surgical, Just Took A Tumble

Top 3 Health Care Stocks You'll Regret Missing In Q2 - iRhythm Holdings (NASDAQ:IRTC), Anbio Biotechnolog

PROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

PROCEPT BioRobotics Corporation (PRCT) Q1 2026 Earnings Call Transcript

PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates

PROCEPT BioRobotics: An Undervalued Surgical Robotics Growth Story (NASDAQ:PRCT)

PROCEPT BioRobotics launches HYDROS system in UK

Tuesday’s insider activity: Major buys at PROCEPT and Mesa Labs

Procept Biorobotics director Desai buys PRCT shares worth $10.4m

Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares